Supporting Breakthroughs and Best Practices

The xIQ Family of Companies delivers market access, market messaging, and market engagement analytics, strategies, and support services to help top-level decision-makers in the healthcare, education, and social-services sectors to improve revenues, earnings growth, and competitiveness around solutions that improve the well-being, productive capacity, and socioeconomic status of individuals, organizations, and communities.

Leadership Team

Please refer to the hyperlinked LinkedIn profiles and Company websites.

Tony Page, MSc, MBA
Chief Executive Officer

Voxx Analytics and the xIQ Family of Companies
12862 Garden Grove Blvd., Suite B
Garden Grove, CA 92843 USA

  • Page has more than 30 years of experience creating and delivering industry-transforming strategic intelligence solutions to conscious capitalists in the health, education, and social-service sectors.
  • In his past career in the U.S. intelligence community, Page led critical global intelligence operations on behalf of multiple strategic-analysis organizations in the U.S. and abroad—facilitating the responsible spread of democratic principles worldwide and contributing to global gains in human wellbeing, productive capacity, and socioeconomic development.
  • Foreseeing the near-absolute transparency that data science would create across stakeholders in the U.S. healthcare system—and recognizing the opportunity to create a differential advantage for mission-driven innovators, entrepreneurs, and executives—Tony productized advanced government intelligence methodologies to create a suite of analytical platforms (for market access, market messaging, and market engagement) that could empower healthcare’s “good actors” to overcome outdated modes of business behavior.
  • With the best of the best in BioPharma as subscribers—and with the goal of supporting increasingly high-level stakeholders committed to responsible industry endpoints—the Company’s groundbreaking analytics, strategy, and support services gave forward-looking clients unprecedented insight for executive decision making, delivering an unparalleled degree of internal transparency around their own and competitors’ products, portfolios, and pipelines.
  • Today, Page and his team are leading the charge in bringing performance, outcomes, and impact analytics to a broader base of companies and professional roles—all to support a better functioning society.
  • Page has a Master of Science degree from National Intelligence University and an MBA from the Peter F. Drucker and Masatoshi Ito Graduate School of Management, where he studied with and personally assisted Peter F. Drucker and other world-renowned faculty members.

Daniel Vesely, BA, MBA
President and Chief Operating Officer

Voxx Analytics and the xIQ Family of Companies
12862 Garden Grove Blvd., Suite B
Garden Grove, CA 92843 USA

  • With more than 30 years of experience in world-class brand development, communications, and public affairs, Vesely is supporting the responsible transformation of the U.S. healthcare system by applying skills honed at the highest levels of global politics.
  • Beginning as a journalist in Czechoslovakia in the late 1980s, Vesely was actively involved in the overthrow of the communist regime. He subsequently served as Press Secretary for the Czech Embassy in Washington DC and Senior Policy Advisor to the President of the new Czech Republic, Vaclav Havel—assuring the revitalized nation embodied the best of democratic principles.
  • In recognition of his role in the reconstruction of a democratic nation, he was granted a full scholarship to study with Peter F. Drucker at the Peter F. Drucker and Masatoshi Ito Graduate School of Management within the world-renowned Claremont Colleges. He is one of the few individuals worldwide to receive a letter of recommendation from Drucker himself.
  • Upon graduation, Vesely joined a boutique management consulting firm specializing in preemptive market leadership strategies for companies at the convergence of the healthcare, business-to-business, and information technology (HC-IT-B2B) sectors. 
  • Quickly advancing to Partner, he was instrumental in the Company’s growth for acquisition by an investor-owned X-as-a-Service (XaaS) cloud-based platform development company.
  • Heading the management consulting practice for that organization, Vesely provided guidance to a broad range of healthcare clients interested in (1) adopting impartial health-related data standards, (2) understanding evolving scope-of-practice laws, and (3) implementing new code sets in support of provider-agnostic healthcare research, management, and commerce.
  • Recognizing the need for broad-based industry intelligence work to support healthcare’s most impactful breakthroughs and best practices, Vesely helped a business associate and fellow Drucker MBA alumnus (Tony Page) reacquire ReimbursementIQ (then HealthIQ) from Parexel. 
  • Vesely and Page then co-founded a next-generation version of the xIQ Family of Companies, leading to a rapid series of research, analytics, and consulting innovations (some patented) that created a new gold-standard in market access, messaging, and engagement analytics.
  • Daniel earned his MBA with high honors from the Drucker School of Management, and an emphasis in strategy, general management, and marketing. His undergraduate degree is in journalism and public relations from the Charles University in Prague, the Czech Republic.

Ryan Peeler, BSc, MBS
Chief Innovation Officer

Voxx Analytics and the xIQ Family of Companies
12862 Garden Grove Blvd., Suite 250
Garden Grove, CA 92843 USA

  • Peeler leads Voxx Analytics, ReimbursementIQ’s sister company focused on network analytics, content analytics, and impact analytics. 
  • He pioneered the use of technology-enabled network analytics—using advanced algorithms
    and machine learning to identify and map relationships among various key opinion leaders
    (e.g., science KOLs, market access KOLs, and outcomes-focused KOLs) in support of legitimate healthcare breakthroughs and best practices. 
  • His deliverables help Health Economics, Medical Affairs,Market Access, HEOR/Value, and Benefit Plan Design experts build product awareness, market access, and real-world evidence (RWE) in support of the proper use of novel healthcare interventions, such as new pharmaceuticals, biologics, medical devices, medical foods, healthcare services, and self-care interventions.
  • Peeler’s peer-reviewed articles have appeared in scientific, technical, and medical (STM) journals on genetics, evolution, climate change, natural language processing, and network analysis. He has contributed to text books on biomedical semantics, evolution through hybridization, and business communications—and he holds a patent in network analytics.
  • Keeping Voxx Analytics at the forefront of healthcare data science since 2006, Peeler and his team recently earned the Company a Cool Vendor designation from Gartner (one of only five Cool Vendors in all of the Life Sciences). 
  • As an undergraduate at the University of Georgia, Peeler double-majored in Biology and Genetics. He received his Master of Business and Science (MBS) from the Keck Graduate Institute of Applied Life Sciences in Claremont, California, where he focused on strategy, leadership, management, entrepreneurship, and product innovation.
  • An amateur magician and stand-up comic with a penchant for brewing beer, Peeler quips that he was Time Magazine Person of the Year in 2006 (the year of “You”). He was featured in OC Metro’s “Forty under 40” issue in 2013 and enjoys woodworking, 3D printing, and not overanalyzing in his cherished roles as father and husband.

Edward Silverman, PhD
Chief Data Officer

Voxx Analytics and the xIQ Family of Companies
12862 Garden Grove Blvd., Suite 250
Garden Grove, CA 92843 USA

  • Ed Silverman is a life science expert, scientific problem-solver, and biomedical communications specialist who offers world-class competencies in data analytics, scientific collaboration networks, and evidence-based criticism of biomedical publications.
  • Silverman’s ability to create breakthroughs and best practices in data science and drug development stems from strong bench-science capabilities and a translational mindset. He has not only advanced the fields of differential gene expression, monoclonal antibody development, and memory retention and loss; but also developed a novel assay for measuring anti-fungal properties, a method for assessing the brain impact of cellular telephones, and a market-leading system for assuring the commercial success of groundbreaking biopharmaceuticals.
  • With training in molecular biology, genetics and epigenetics, and biochemistry, Silverman manages clients in the BioPharma and MedTech industries and oversees the Voxx Analytics team focused on Key Opinion Leaders (KOLs), Market Access drivers, and Real-World Evidence (RWE) development toward value accountability.
  • An relentless knowledge seeker and practiced public speaker, Silverman previously served as an adjunct professor of Biology at Chapman University; won a Baxter Postdoctoral Fellowship at the world-renowned California Institute of Technology (CalTech); and is widely recognized for his skills in medical writing, data analytics, and visualization technologies.
  • A committed father of three, former Eagle Scout, and advocate of Boy Scouts of America and Girl Scouts of the USA, Silverman holds a PhD in Biological Sciences from City of Hope Graduate School of Biological Sciences and an undergraduate degree in Molecular Biology from Johns Hopkins University.

Mariam Eghbal-Ahmadi, MSc, MBA
Chief Client Officer

Voxx Analytics and the xIQ Family of Companies
12862 Garden Grove Blvd., Suite 250
Garden Grove, CA 92843 USA

  • Mariam Eghbal-Ahmadi is a principled, discerning, and compassionate value strategist who has worked with the xIQ Family of Companies for nearly two decades, transitioning from managing global business operations to identifying high-impact, next-generation health industry solutions that empower clients to achieve performance jumpstarts or turnarounds—all while helping to improve the human condition.
  • Skilled in mobilizing transdisciplinary and cross-functional teams around mission, Eghbal-Ahmadi applies advanced qualitative research, analytics, and strategies to design market-leading features and benefits into clients’ next-generation products, services, and solutions. She has an uncanny ability to see what has already happened that has yet to have full impact, and she is known for her resiliency and willingness to roll up her sleeves to get any task completed. 
  • Because of her relentless focus on quality, timeliness, and effectiveness, her clients gain groundbreaking insights and capabilities that empower them to establish new gold standards in market, corporate, and product performance. 
  • Internally, Eghbal-Ahmadi has broad and deep knowledge of the three pivotal xIQ platforms (i.e., market access, market messaging, market engagement) and wields them to help peers build intuitive and impactful intelligence products. As Managing Director of Market Analytics and Strategic Intelligence, she (1) oversaw corporate operations in the U.S., India, and the Czech Republic; (2) expanded data harvesting capabilities into emerging digital marketing channels; and (3) broadened marketing content collection through new provider networks in emerging European markets (outside EU5).
    As Director of Operations, Program Director, and Project Director, she designed and oversaw competitive intelligence initiatives on behalf of BioPharma, MedTech, and Healthcare organizations.
  • Eghbal-Ahmadi has been serving as an adjunct professor since 2013, at the California State University,
    Los Angeles, College of Business and Economics; and she is a lecturer in the Master of Science in Healthcare Decision Analysis (HCDA) Program at the University of Southern California School of Pharmacy and Department of Clinical Pharmacy and Pharmaceutical Economics and Policy.
  • A dedicated parent and charitable advocate for healthy families and human empowerment, she has volunteered on adult health literacy initiatives, invested in the emotional development of foster children, and donated to a broad range of non-profit causes ranging from research institutes to food pantries.
  • Eghbal-Ahmadi was previously a Laboratory Manager and Research Associate at the University of California, Irvine, Departments of Anatomy and Neurobiology and Pediatrics. She has numerous scientific, technical, and medical (STM) publications; holds a Master of Science Degree in Biology and Neurobiology from the University of California at Irvine; and earned an MBA from the Peter F. Drucker and Masatoshi Ito Graduate School of Management.

Synthia Laura Molina, BSc, MBA
Value Strategist and VP of Strategic Business Development 

ReimbursementIQ and the xIQ Family of Companies
12862 Garden Grove Blvd., Suite 240
Garden Grove, CA 92843 USA
Phone: 877-777-0149 
Fax: 877-777-0164

Managing Director

Central IQ, Inc.
2243 Martin Ct., #112
Irvine, CA 92612 USA
Phone: 813-920-4001
Fax: 813-920-4011

  • Synthia Laura Molina is an expert in market, corporate, and development—and she currently focuses on value creation at the convergence of the healthcare, education, and social services sectors.
  • With three decades of experience as a tech-savvy, content-producing program director, earnings driver, and social benefit strategist, she is skilled in (1) accelerating market, corporate, and product development by clarifying mission; (2) creating and measuring what matters; and (3) empowering talent with purpose, competencies, and enabling technologies.
  • Prior to realigning with ReimbursementIQ—a company Molina co-owned in the 1990s—Molina founded Central IQ and Mission Accomplished, where she delivered industry analysis, strategic planning, and business development services to help healthcare pioneers lead emerging markets.
  • Molina developed strategy, leadership, and general management expertise through progressive positions in quality control, laboratory sciences (microbiology and chemistry), quality assurance, regulatory affairs, R&D, marketing research, product development, product management, marketing management, sales, sales management, business development, operations management, and various C-Suite roles.
  • In the early 2000s, as CEO of ABC Coding Solutions, she secured federal review of the company as a national standard-setting organization for HIPAA-compliant codes representing allied and public health, nursing, complementary and alternative medicine, and other integrative healthcare practices. 
  • In the mid-1990s (while serving as a corporate director, strategic advisor, and content developer for HealthIQ–a health economics, reimbursement strategy, and hub service pioneer subsequently acquired by Elsevier and Parexel), she directed the Drucker MBA program at The Claremont Colleges and helped the Drucker School achieve even greater national prominence among management education programs. 
  • Between 1990 and 1995, she served as Director of Marketing Research and Vice President of Industry and Business Development for HealthIQ, supporting more than a dozen brand-name BioPharma and MedTech companies and facilitating the growth of Quantum Health Resources from startup to $200 million in revenue.
  • In the late 1980s (while completing her graduate studies), she was hired to save over a million lives and resolve a catastrophic international crisis for Baxter Healthcare Corporation and the American Red Cross, involving hundreds of production lots of HIV and Hepatitis-tainted blood products. She audited dozens of plasma donation centers and blood banks in relation to quality assurance practices. She drafted the companies’ quality transformation roadmaps to assure product and patient safety—and she made CxO level recommendations essential to rebuilding worldwide trust in the Baxter and ARC brands.
  • In the mid-1980s (while pursuing an MBA), she was hired to resolve a devastating FDA 483 letter and co-led a regulatory affairs, quality systems, and new product development turnaround for Ioptex Research, Inc., supporting its nine-figure acquisition by Smith & Nephew.
  • In the early 1980s (while completing her undergraduate studies), she managed quality engineering projects in the quality control department and science laboratories of a newly acquired Johnson & Johnson subsidiary.
  • Molina’s consulting engagements have included corporate planning and product/portfolio optimization initiatives for brand-name companies (such as Abbott, AmerisourceBergen Corporation, Amgen, Bristol-Myers Squibb, Eli Lilly, Genentech, GlaxoSmithKline, Merck, Novo Nordisk, Pfizer, and Philips Medical Systems), and for market-transforming information technology and electronic commerce companies (such as Manhattan Associates, WebMD, and VeriFone).
  • Molina has written dozens of articles in health industry trade publications and is a go-to resource for healthcare authors, speakers, and the press. An author, public speaker, and subject matter expert on health industry and corporate evolution, Molina has presented at dozens of health industry conferences on topics such as strategic management, product portfolio evaluation and planning, health economics, outcomes research, disease management programs, performance and outcomes-based payment systems, gain-sharing initiatives, health-related data standards, consumer-driven healthcare, health information system interoperability, and social HMOs.
  • A University of California Alumni Scholar and recipient of the 2004 Distinguished Alumni Service Award at Claremont Graduate University, she earned honors in the Premedical Science programs at the University of California at Berkeley and Pomona College, holds a Bachelor of Science degree in Management and Organizational Behavior from the University of La Verne (completed while working full time in the health industry), and was ranked first in her class in the Drucker MBA program at the Peter F. Drucker and Masatoshi Ito Graduate School of Management, near Los Angeles. She currently serves on the Drucker Industry Advisory Board and does volunteer TV camera work, content development and syndication, and career coaching.

Jan Alvarado, BA
General Manager

ReimbursementIQ and the xIQ Family of Companies
12862 Garden Grove Blvd., Suite 240
Garden Grove, CA 92843 USA
Phone: 877-777-0149 
Fax: 877-777-0164

  • Offering more than 30 years of market, corporate, and product development experience for pioneering healthcare companies, Jan Alvarado has led ReimbursementIQ, a third-party payment consultancy (in its various corporate forms), since 1991. With P&L responsibility, a background in cross-functional program and project management, and a demonstrated track record of optimizing organizational performance through M&A events, she has over 25 years of experience securing highly favorable, precedent-setting coverage, coding, and reimbursement policies on behalf of healthcare providers, health industry manufacturers, and patient advocacy groups.
  • Alvarado offers broad and deep knowledge of healthcare finance, healthcare administration, and healthcare delivery systems—and she specializes in assisting pharmaceutical, biotech, medical device, medical food, and healthcare service companies with the development and implementation of creative pre- and post-launch strategies, operations, and tactics that minimize third-party payment challenges and facilitate patient access to worthy new treatment modalities. Her market access skills include legislative policy analysis, third-party payment analysis, strategic reimbursement planning, coding analysis and acquisition, insurance verifications, eligibility determinations, prior authorizations, strategic coding, insurance billing, insurance claims management, payment precedent-setting, reimbursement optimization, and denial management.
  • Having worked on groundbreaking healthcare finance, administration, and innovation projects for startups, small to mid-sized business (SMBs), and multinational corporations (MNCs), Alvarado has managed strategic planning programs, new product development projects, reimbursement helplines, patient assistance programs, and insurance billing operations to benefit not only client-company shareholders but also other critical constituencies. She provides mission-critical strategic guidance to a broad range of stakeholders concerned with ensuring cost-effective and medically necessary care is properly covered, coded, and reimbursed.
  • Alvarado holds a Bachelor of Science degree from the University of California at Irvine, is involved in a broad range of value-related innovations, and is an industry pioneer in 360-degree impact analytics.

Susan Horn, BA 
Director of Operations

ReimbursementIQ and the xIQ Family of Companies
12862 Garden Grove Blvd., Suite 240
Garden Grove, CA 92843 USA
Phone: 877-777-0149 
Fax: 877-777-0164

  • Susan Horn has more than 25 years of experience developing and implementing third-party payment strategies for health industry pioneers leading cutting-edge pharmaceutical, biologics, medical device, food-as-medicine, acute care, group practice, and alternate site markets.
  • As ReimbursementIQ’s Client Operations Director, she supports senior managers in developing go-to-market strategies for new medical products; trains leadership teams, market access professionals, and patient access specialists; and oversees payment precedent-setting projects, reimbursement helplines, and compassionate care programs.
  • With more than 10 years of revenue cycle management experience for durable medical equipment (DME), home healthcare (HHC), and home infusion companies, Horn is an expert in capitated contracting, value-based purchasing, coverage policy solicitation, new code acquisition, insurance billing strategies, claims denial management, and more.
  • Her career highlights include securing coverage for a category-creating Orphan Drug for Severe Combined Immunodeficiency (SCID) that enabled children with the “Bubble Boy Disease” (adenosine deaminase deficiency) to live normal lives; establishing payment precedents (under both medical benefits and pharmacy benefits) for medical foods essential to the survival of children with failure-to-thrive diagnoses; and winning denial-related appeals centered on drugs’ off-label uses in treating cancer patients.
  • Horn holds a Bachelor of Arts degree in Social Welfare from California State University at Long Beach and earned supplemental credentials in geriatric health optimization.

Zenobia Walji, BA, MBA
Value Strategist and Strategic Advisor

ReimbursementIQ and the xIQ Family of Companies
12862 Garden Grove Blvd., Suite 240
Garden Grove, CA 92843 USA
Phone: 877-777-0149 
Fax: 877-777-0164

  • Zenobia Walji is a MedTech industry expert, volume-to-value (V2V) transition specialist, and global marketing strategist with 25+ years of leadership and organic-growth experience serving leading multinational corporations (MNCs) within and beyond U.S. markets. 
  • She has held local, national, and global leadership roles in strategic planning, marketing, and sales—navigating both fee-for-service (FFS) payment systems and capitated, value-based contracting (VBC) environments for brand-name medical device companies including Johnson & Johnson, Medtronic, and Stryker.
  • Walji’s ability to drive top-line and bottom-line growth (e.g., for established or acquisitive new [$100M], mid-sized [$500M] and large [$2B] medical device businesses) was developed through multidisciplinary, cross-functional, and trans-geographic headquarter roles in the U.S. and 
  • Known for breakthrough business insights, a servant-leadership style, and performance standard-setting by leadership example, Walji has successfully led efforts to build and then implement multi-year worldwide strategic plans across radically varied public health policy and healthcare financing systems. Her passion for people—combined with her insightful understanding of country-specific medical-practice drivers—has won her the support of C-Suite executives; key opinion leaders (KOLs) in science, medicine, and technology (STM); and surgical-allied professionals. She offers unparalleled expertise in influence analytics, complex problem solving, and stakeholder alignment toward improved economic, clinical, and humanistic outcomes (ECHOs).
  • Having started as a U.S-based sales rep and having quickly moved into international assignments serving teaching hospitals and other world-class healthcare provider organizations, Walji was a pioneer in driving the adoption of new technology,  real-world data (RWD) collection, real-world evidence (RWE) building, and real-world value-creation. As far back as 1989, she engineered customer-centric win-win business relationships and executed exclusive multi-year contracts with performance guarantees that positioned both Med Tech manufacturers and their change-resistant customers for sustainable, double-digit earnings growth based on clinical performance, business outcomes, and community impacts.
  • Walji earned a Bachelor of Arts degree in European Studies and Philosophy from Claremont McKenna College (a top-10 liberal arts college) and an MBA in International Marketing from the Peter F. Drucker and Masatoshi Ito Graduate School of Management at Claremont Graduate University. She is fluent in six languages and is widely viewed as a compassionate “pressure tester” who brings extreme methodological rigor and fresh eyes to client assignments.

Gerace Chuang Gerace, BSc, MBA
Value-Based Contracting and Payment Analytics Advisor

ReimbursementIQ and the xIQ Family of Companies
12862 Garden Grove Blvd., Suite 240
Garden Grove, CA 92843 USA
Phone: 877-777-0149 
Fax: 877-777-0164

  • Gerace Chuang Gerace is a CxO-level quantitative researcher, analyst, and strategist—and pioneering contract engineer—with more than 25 years of experience evaluating and reengineering stakeholders’ financial relationships to optimize economic, clinical, and humanistic outcomes (ECHOs) of care.
  • In the early 1990s, as a senior research analyst and strategic project director for HealthIQ, Gerace applied her market-leading understanding of third-party payment drivers in formulating revenue-optimization strategies and developing pioneering business plans for Healthcare 100 companies—ensuring biopharmaceutical, medical device, and healthcare provider organizations would thrive during the transition from indemnity health insurance plans to managed care plans.
  • In the mid 1990s, Gerace assured quarter-over-quarter earnings growth for FPA Medical Management, a risk-bearing managed care organization (MCO) by co-designing Health Maintenance Organization (HMO) and Preferred Provider Organization (PPO) service offerings; developing clinical, financial, and administrative scorecards and dashboards; and then running technology-enabled multivariate analyses across claims databases, identifying and managing key performance drivers across a $500 million book of business, and 600,000 capitated members. 
  • In this role, Gerace ran analytics in support of acquisition strategies; pioneered risk-sharing and gain-sharing contracts between self-insured employers, health plans, and regional healthcare provider organizations; and developed quantitative models to support M&A offers, facilitate shared-risk contracts, negotiate rates, audit performance, recover shared-risk settlements, and position contracting parties for improved clinical, financial, and administrative performance over time. She also accelerated the growth of a market-leading health plan by performing industry analyses, due diligence based organizational performance reviews, and scenario-based valuation appraisals of hospitals, medical groups, and other healthcare entities. Her research work extended from longitudinal claims analytics to quantitative reviews of member Independent Practice Associations (IPAs), ambulatory care facilities, specialty medical groups, and freestanding clinics—all in support of direct-to-employer contracts and quality-assured participating providers. Extending from physician report carding and in-depth service-line analyses to pro-forma financial statement development for business plans, her quantitative analyses were central to the MCO’s market-leading PPO-network development, capitated contracting, and fee-for-service negotiating strategies.
  • In the early 2000s, Gerace served as Director of Operations for an oncology management group at the world-renowned City of Hope, overseeing a broad-range of operating margin and clinical outcomes determinants including facility management, human resource management, business and clinical process development, information system selection and oversight, and more. 
  • In a concurrent role, she served as the Manager of Business Development for the City of Hope hospital, running reimbursement forecasts, net present value (NPV), and internal rate of return (IRR) analyses in relation to new business opportunities ranging from new staffing and medical practice acquisition models to new clinical service lines (e.g., building new treatment centers and acquiring new imaging technologies).
  • Following her time at City of Hope, Gerace co-engineered CxO and VP dashboards and ran high-level analytics for seven senior executives (including the Vice Presidents of Marketing and Sales)—working closely with the information technology teams in running quantitative analyses to support global market reviews, scenario-driven business planning, marketing strategies, capital equipment leasing models and supply pricing, territory realignments, compensation and commission schedule development, and other mission-critical initiatives.
  • Over the past 15 years, Gerace led an International Arts business, developing an online brand and revenue stream so strong that it grew quarter over quarter even through the Great Recession. She rejoined the original HealthIQ leadership team in 2018, committed to building 360-degree impact accountability into value-based contracts to help critical health industry stakeholders achieve the Triple/Quadruple Aim of reduced per capita costs, improved population health, and enhanced patient/provider experiences.
  • Gerace earned a Bachelor of Science degree in Biology with a minor in Social Ecology from the University of California in Irvine. She holds an MBA in Finance and Healthcare from the University of Southern California.

Analytics, Strategy, and Support Services

  • The xIQ Family of Companies is committed to keeping you at the forefront of the volume-to-value (V2V) transition. 
  • Being an innovator or early-adopter isn’t always a good idea; however, in a V2V contracting environment, being first matters.
  • Real-world data/evidence (RWD/RWE), value-based contracting (VBCs), outcomes-based compensation (OBC) agreements can create or block access to millions of covered lives and thousands of providers at a time for years at a time.
  • Our services are designed to gain you the access and strategic partnerships you deserve and prevent less value-focused players from diverting your revenue and taking your rightful place at the forefront of the industry.